DPNCheck Logo

Biomedix Signs Collaboration Agreement with NeuroMetrix DPNCheck

WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets.  NeuroMetrix and Biomedix provide complementary diagnostic tests to physicians and health plans. Read more…

Drug Test